Alborz Daru’s Pivotal Role at Iran’s 14th National Clinical Pharmacy Congress

According to the Barekat Health and Pharmaceutical Group, the 14th National Congress of Clinical Pharmacy in Iran concluded successfully from May 28 to 30, with extensive participation from professors, researchers, pharmaceutical industry experts, and senior health system officials at the Razi International Conference Center.

This edition of the congress, themed “Dynamic Pharmacy: Interdisciplinary Collaboration in Medication Management,” explored the latest advancements in the field of clinical pharmacy.

Key topics addressed included strengthening collaboration between pharmacists and physicians within the healthcare system, fostering innovation and applied research through interdisciplinary cooperation, and updating specialized knowledge in clinical pharmacy via scientific panels and expert sessions.

Simultaneously, the specialized exhibition of pharmaceuticals and health products featured leading domestic pharmaceutical companies. Among the prominent participants, Alborz Daru — a subsidiary of the Barkat Health and Pharmaceutical Group and a respected name in the pharmaceutical industry — actively contributed to the event. In addition to showcasing its general product line, Alborz Daru unveiled a new series of specialized supplements, which received enthusiastic acclaim from attendees and industry specialists alike.

During the congress, Alborz Daru’s executives engaged in multiple discussions and meetings with active pharmacists from pharmacies nationwide, as well as senior health officials, including Dr. Mahdi Pirsalehi, the chairman of Iran’s Food and Drug Administration. These exchanges highlighted the company’s achievements and facilitated in-depth conversations regarding the quality, efficacy, and features of its supplement products.

Notably, the presence of top health authorities such as Dr. Ali Jafarian, Deputy Minister of Health, and Dr. Mahdi Pirsalehi, the chairman of Iran’s Food and Drug Administration underscored the growing significance of clinical pharmacy within the country’s healthcare structure. They emphasized the critical need to enhance the role of clinical pharmacists and reiterated the Ministry of Health’s ongoing commitment to support the development of this vital field.

Another highlight of the 14th Congress was a series of scientific lectures by distinguished professors and specialists from leading universities, including Sharif University of Technology. These experts elucidated the importance of dynamic pharmacy and interdisciplinary collaboration in elevating the quality of pharmaceutical care, stressing the necessity of integrating knowledge across various medical and engineering disciplines.

The 14th National Clinical Pharmacy Congress, by fostering interaction among academia, industry, and health policymakers, marked a milestone in advancing clinical pharmacy, improving pharmaceutical service quality, and promoting interdisciplinary cooperation.